Semaglutide GLP-1: With dual benefits in managing type 2 diabetes and obesity, Semaglutide has been shown to result in an average weight loss of 14.9%
Without enough protein, weight loss may come from both muscle and fat, which can make patients feel weaker, colder, and more tired over time
Optimize hormones through HRT and growth hormone peptides
IUPHAR review-Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
In a zebrafish model, compared with C3-carnitine, C18-carnitine and C18:1-carnitine can induce the inhibition of OXPHOS, interfere with the energy supply of cardiomyocytes, and lead to a significant impairment of cardiac systolic function, which manifests as a decreased heart rate and reduced shortening of the atrial and ventricular fractions [21]
Mechanistically, leptin induces synthesis of glial cell line-derived neurotrophic factor (GDNF) within the ENS, preserving myenteric cholinergic neuron activity via GDNF-mediated neuroprotection